Jyothy Labs Limited has submitted a regulatory disclosure to BSE Limited and the National Stock Exchange of India Limited intimating a scheduled investor/analyst meeting. The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The meeting is a one-on-one session with Nalanda Capital, scheduled to take place on September 23, 2026. The company notes that this schedule is subject to change due to exigencies on the part of either the investor or the company.
A key disclosure states that no Unpublished Price Sensitive Information (UPSI) is proposed to be shared by the company during this investor meeting. The latest Investor Presentation is available on the company's website at www.jyothylabs.com.
The letter is signed by Shreyas Parag Trivedi, Head – Legal & Company Secretary, on behalf of Jyothy Labs Limited. The company's Corporate Identification Number (CIN) is L24240MH1992PLC128651, with its registered office at 'Ujala House', Ramkrishna Mandir Road, Kondivita, Andheri (East), Mumbai 400059.